Summary of publication | ||
---|---|---|
Name of intervention | Â | |
Study title | Â | |
Author(s) | Â | |
Year | Â | |
DOI or URL | Â | |
Protocol available online? (Provide link) | Â | |
Prior feasibility and pilot testing? Y/N | Â | |
Study design (e.g. RCT, observational, case–control study, feasibility, pilot) |  | |
Methods (quantitative, qualitative, mixed methods) | Â | |
Aims/purpose of study | Â | |
Location/setting (e.g. country, number of participating centres, primary/secondary care, specialty) | Â | |
Demographics of population | ||
Mean age (SD) | Â | |
Female: # (%) | Â | |
Population: Condition(s) | Â | |
Inclusion/exclusion criteria (copy and paste) | Â | |
Mean duration of symptoms/time since diagnosis | Â | |
Integration of appropriate theory | ||
Has a published/validated development framework been cited? Y/N (if yes, please specify, e.g. intervention mapping, person-based approach, Centre for eHealth Research and Disease Management (CeHRes) development approach) | Â | |
Targeted health behaviour(s) | Â | |
Consideration of motivational/behaviour change theory to promote self-management behaviour? Y/N (if yes, please specify theory used, e.g. self-efficacy theory, self-determination theory, MoVo process model, COM-B model of behaviour) | Â | |
Specification of BCTs utilised and proposed mechanism(s) of action? Y/N (if yes, please list BCTs + corresponding conceptual MoAs; requires conscious acknowledgement of techniques used and conceptual frameworks by which they promote behaviour change, e.g. an app may display autonomy-supportive language, but not have considered how or why this promotes behaviour change, or the motivational framework supporting its use) |  | |
Consideration of theoretical frameworks to promote app engagement? Y/N (if yes, please specify theory or framework used, e.g. persuasive systems design, self-determination theory-based taxonomy of app features) | Â | |
Intervention development | ||
aTransparency regarding funder | Â | |
aTransparency on data ownership | Â | |
aAdherence to data protection and regulatory frameworks | Â | |
Acknowledgement of alignment with clinical guidelines | Â | |
Stage of development (e.g. pilot/feasibility testing, deployed) | Â | |
Strategies of development (copy overview of methodology if available) | Â | |
aCo-design with patients? Y/N | Â | |
aCo-design with HCPs? Y/N (if yes, please specify professions) | Â | |
Co-design with others? (Y/N) (if yes, please specify, e.g. stakeholder committee, behavioural scientists, HCI researchers) | Â | |
Is any training/education provided to the patients on using the technology? | Â | |
Is any training/education provided to the HCP on using the technology? | Â | |
Self-management intervention content (please specify details, list developed using guidance from EULAR (Nikiphorou et al., 2021) [26] and patient organisations [NASS, NRAS, versus arthritis]) | ||
aEvidence-based, up-to-date, scientifically justifiable content | Â | |
Disease education | Â | |
Flare management | Â | |
Coping with pain | Â | |
Coping with fatigue | Â | |
Managing sleep | Â | |
Medication education | Â | |
Medication management (e.g. reminders) | Â | |
Joint decision-making | Â | |
Psychological support (e.g. cognitive behavioural therapy) | Â | |
Mental health assessment | Â | |
Physical activity/ stretching | Â | |
Physiotherapy techniques guided or created by a physiotherapist | Â | |
Occupational health (work-related) guidance | Â | |
Smoking | Â | |
Alcohol intake | Â | |
Nutrition | Â | |
Other lifestyle advice and support (please specify) | Â | |
Social support | Â | |
Clinical action plans | Â | |
Problem-solving | Â | |
Signposting to patient organisations | Â | |
Signposting to advice line/HCP contacts | Â | |
Signposting to other resources (please specify) | Â | |
aTailoring/personalisation | Â | |
Other | Â | |
APP features, according to SDT motivational taxonomy (Villalobos-Zúñiga et al., 2020) — Y/N | ||
Reminders | Â | |
Goal setting | Â | |
Motivational messages | Â | |
Pre-commitment | Â | |
Activity feedback | Â | |
History (e.g. progress graph) | Â | |
Log/self-monitoring | Â | |
Rewards | Â | |
Performance sharing | Â | |
Peer challenging | Â | |
Messaging (peer to peer) | Â | |
Messaging (to HCPs — please specify asynchronous/synchronous + purpose) |  | |
aCommunication moderation | Â | |
Others (please specify) | Â | |
Operating system (i.e. iOS or Android) | Â | |
Barriers/facilitators to engagement | ||
Barriers to engagement with digital intervention | Â | |
Barriers to engagement with self-management behaviours | Â | |
Facilitators of engagement with digital intervention | Â | |
Facilitators of self-management behaviours | Â | |
Measures of effectiveness | ||
Self-management support measures, e.g. patient activation, self-efficacy | Â | |
What objective outcomes are used (e.g. accelerometer data, spinal mobility? | Â | |
What clinician-reported outcome measures (ClinROs), diaries, or other tools are used? | Â | |
What patient-reported outcome measures (PROMs) are used? | Â | |
What is used to measure intervention adherence? | Â | |
What is used to measure intervention acceptability? | Â | |
What is used to measure intervention usability? | Â | |
At what time points are outcomes assessed? | Â | |
Results/description of effectiveness | ||
Was the intervention effective (qualitative)? | Â | |
Was the intervention effective (quantitative)? | Â | |
Adherence? | Â | |
Acceptability? | Â | |
aUsability? (Across all ages, abilities) | Â | |
aCost-effectiveness? | Â | |
Contextual influences on intervention success (economic factors, available resources, local healthcare system structure) [53] | Â | |
Conclusions, clinical implications, future directions? | Â | |
Limitations (of the intervention) | Â | |
Methodological strengths/limitations for evaluation of effectiveness | ||
Study design | Â | |
Strengths (of the study design) | Â | |
Limitations (of the study design) | Â |